Tumor Susceptibility Gene 101 (TSG101) (N-Term) Peptid
TSG101
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5510860
Kurzübersicht für Tumor Susceptibility Gene 101 (TSG101) (N-Term) Peptid (ABIN5510860)
Target
TSG101
(Tumor Susceptibility Gene 101 (TSG101))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- MMRSRSKSPR RPSPTARGAN CDVELLKTTT RDREELKCML EKYERHLAEI
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-TSG10 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
-
Hintergrund
-
TSG10 may play a role in the sperm tail fibrous sheath, a major sperm tail structure.
Alias Symbols: TSGA10,CEP4L,
Protein Size: 297 -
Gen-ID
- 80705
Target
-
Sie sind hier:
